Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D7NLU3
|
|||
| Drug Name |
Taniraleucel
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Malignant glioma [ICD-11: 2A00.0; ICD-9: 191] | Phase 1/2 | [1] | |
| Company |
Celularity
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05218408) A Phase I/IIa Open Label Multicenter, Non-Randomized, Trial to Assess the Safety and Efficacy of CYNK-001in Combination With Recombinant Human Interleukin-2 in Adults With Recurrent Resection Eligible IDH1 Wild-type Glioblastoma. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.